Close Menu
NEW YORK – The Chan Zuckerberg Initiative and Biohub said on Tuesday they are working with the University of California, San Francisco and Stanford University to increase the Bay Area's novel coronavirus testing capacity by investing in molecular diagnostic platforms from GenMark Diagnostics.
 
The organizations have formed a so-called COVID-19 task force to invest in two GenMark ePlex sample-to-answer molecular diagnostic platforms, one for a CLIA lab at the UCSF Helen Diller Medical Center in Parnassus Heights and one for a CLIA lab at UCSF's Primary Care clinic in C

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.

Mar
17
Sponsored by
IONPath

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.